Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Fillerâ„¢
News





- Sep 8
- 0 min
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢

- Sep 6
- 4 min
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢


- Aug 12
- 1 min
Biosenta Inc. announces further advances in research and development of Tri-Fillerâ„¢


- Aug 11
- 1 min
Solution fighting a drug-resistant fungus in hospitals of U.S. and Canada


- Aug 8
- 5 min
Biosenta announces further advances in research and development of Tri-Fillerâ„¢

- Jul 17
- 2 min
Biosenta announces termination of joint venture and issuance of securities

- Jun 23
- 7 min
Biosenta announces entering into of agreement to terminate joint venture

- May 31
- 1 min
Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.

- Oct 26, 2022
- 1 min
Summit-bound CEO sees promising future for Edmonton region

- Jul 14, 2022
- 1 min
University of Calgary researchers encouraged by early findings in the fight against germs

- May 26, 2022
- 3 min
University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry

- Jan 26, 2021
- 1 min
01/26/2021 - Biosenta Announces Record Revenues

- Dec 22, 2020
- 1 min
12/22/2020 - U.S. Partner Secures Licensing Rights

- Sep 24, 2020
- 3 min
09/24/2020 - Biosenta and University of Calgary enter into a four year partnership

- Sep 14, 2020
- 2 min
09/14/2020 - Biosenta Announces Royalty License Agreement for North American Distribution